BrendaJaneWeigelMD

Pediatric Hematology & Oncology • Memphis, TN

Vice President Clinical Research Administration, St. Jude Children's Research Hospital

Join to view full profile

Dr. Weigel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weigel's full profile

Already have an account?

Office
262 Danny Thomas Place
MS 720
Memphis, TN 38105
Phone+1 901-738-6971

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1996 - 2000
Michael G. DeGroote School of MedicineClass of 1993

Certifications & Licensure

MN State Medical License 2000 - 2025
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com

Clinical Trials

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia Start of enrollment: 2004 Mar 01
Completed
Phase 1
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma Start of enrollment: 2006 Jul 01
Completed
Phase 3
HSCT for High Risk Inherited Inborn Errors Start of enrollment: 2006 Sep 01
Completed
Phase 2
Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia Start of enrollment: 2008 Jan 01
Terminated
Phase 1
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia Start of enrollment: 2013 Dec 01
Withdrawn
Phase 2
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2012 Nov 14
Completed
Phase 1
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Start of enrollment: 2013 Nov 01
Completed
Phase 1
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medici...
Andrew Dj Pearson, Sabine Mueller, Mariella G Filbin, Jacques Grill, Cynthia Hawkins
European Journal of Cancer. 2025-01-13
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other PediatricFusion-Positive Solid Tumors (Children's Oncology Group ADVL1823).
Theodore W Laetsch, Stephan Voss, Kathleen Ludwig, David Hall, Donald A Barkauskas
Journal of Clinical Oncology. 2024-12-09
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sapna Oberoi, Frank M Balis
Cancer. 2024-11-15

Press Mentions

TWiPO #93: CureWorks & Caring Cross: Pathways to Advance Cell & Gene Therapy with Dr. Rimas OrentasJanuary 20th, 2022
Best of the Best: Minnesota Monthly Honors over 400 of Our Physicians as 2021 “Top Doctors”August 26th, 2021
Bringing the Best to You: Hundreds Honored as “Top Doctors” by Minnesota Monthly in 2020August 27th, 2020
Join now to see all